Sabra Health Care REIT, Inc. (SBRA) stock
Close on Nov 17, 2026Market cap $5.17BP/E 77.9Yield 5.93%
Earnings
Sabra Health Care REIT's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Sabra Health Care REIT's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 11, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 2, 2026after the close | $249.57M | +31.3% | $0.11 | $0.39 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 3, 2026during market hours | – | – | – | – | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 29, 2026during market hours | $221.75M | +20.8% | $0.16 | – | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 12, 2026during market hours | $211.90M | +16.2% | $0.11 | $0.36 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 5, 2025during market hours | $190.04M | +6.8% | $0.09 | $0.36 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 4, 2025during market hours | $189.15M | +7.4% | $0.27 | $0.37 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 5, 2025during market hours | $183.54M | +10.1% | $0.17 | $0.35 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 19, 2025during market hours | $182.35M | +11.6% | $0.19 | $0.35 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 31, 2024during market hours | $178.00M | +10.1% | $0.13 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 7, 2024during market hours | $176.14M | +9.3% | $0.10 | $0.35 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 8, 2024during market hours | $166.75M | +3.4% | $0.11 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 27, 2024during market hours | $163.40M | -1.0% | $0.07 | $0.32 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 6, 2023during market hours | $161.63M | +14.8% | -$0.07 | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 7, 2023during market hours | $161.17M | +3.3% | $0.09 | $0.33 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 3, 2023during market hours | $161.32M | -1.1% | -$0.04 | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 21, 2023during market hours | $164.99M | +21.6% | -$0.37 | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 7, 2022during market hours | $140.76M | +9.5% | -$0.22 | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 3, 2022during market hours | $155.96M | – | $0.07 | $0.39 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 4, 2022during market hours | $163.11M | – | $0.18 | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 22, 2022before the open | $135.66M | – | -$0.11 | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 3, 2021during market hours | $128.59M | – | $0.05 | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 4, 2021during market hours | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | May 5, 2021during market hours | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Feb 22, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020during market hours | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Sabra Health Care REIT's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net IncomeGAAP | FY2026 | $0.27 – $0.28 | – | New | Nov 2, 2026 |
| Net IncomeGAAP | FY2026 | $0.60 – $0.64 | – | New | Feb 12, 2026 |
| Normalized FFOnon-GAAP | FY2026 | $1.54 – $1.55 | – | New | Nov 2, 2026 |
| Normalized FFOnon-GAAP | FY2026 | $1.49 – $1.53 | – | New | Feb 12, 2026 |
| AFFOnon-GAAP | FY2026 | $1.63 – $1.64 | – | Raised | Nov 2, 2026 |
| FFOnon-GAAP | FY2026 | $1.15 – $1.16 | – | New | Nov 2, 2026 |
| Normalized AFFOnon-GAAP | FY2026 | $1.60 – $1.61 | – | Lowered | Nov 2, 2026 |
Guidance vs results
The last range Sabra Health Care REIT gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | EPS (GAAP) | $0.66 – $0.67 | $0.64Σ4Q | Below range |
| FY2025 | Normalized FFO | $1.46 – $1.47 | $1.44Σ4Q | Below range |
Guidance history
Every forecast Sabra Health Care REIT put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 2, 2026 | Normalized FFO | FY2026 | $1.54 – $1.55 | New |
| Nov 2, 2026 | Net Income | FY2026 | $0.27 – $0.28 | New |
| Nov 2, 2026 | Normalized AFFO | FY2026 | $1.60 – $1.61 | Lowered |
| Nov 2, 2026 | AFFO | FY2026 | $1.63 – $1.64 | Raised |
| Nov 2, 2026 | FFO | FY2026 | $1.15 – $1.16 | New |
| Feb 12, 2026 | Normalized FFO | FY2026 | $1.49 – $1.53 | New |
| Feb 12, 2026 | Net Income | FY2026 | $0.60 – $0.64 | New |
| Nov 5, 2025 | Normalized FFO | FY2025 | $1.46 – $1.47 | New |
| Nov 5, 2025 | Net Income | FY2025 | $0.66 – $0.67 | New |
| Nov 5, 2025 | General and administrative expenses | FY2025 | $50.00M | New |
| Nov 5, 2025 | Cash interest expense | FY2025 | $104.00M | Raised |
| Nov 5, 2025 | Normalized AFFO | FY2025 | $1.50 – $1.50 | Raised |
| Nov 5, 2025 | AFFO | FY2025 | $1.46 – $1.47 | Lowered |
| Nov 5, 2025 | FFO | FY2025 | $1.47 – $1.48 | New |
| Aug 4, 2025 | Normalized FFO | FY2025 | $1.45 – $1.47 | Raised |
| Aug 4, 2025 | Net Income | FY2025 | $0.77 – $0.79 | Raised |
| Aug 4, 2025 | FFO | FY2025 | $1.52 – $1.54 | Raised |
| Aug 4, 2025 | Normalized AFFO | FY2025 | $1.49 – $1.51 | Raised |
| Aug 4, 2025 | AFFO | FY2025 | $1.47 – $1.49 | Lowered |
| Aug 4, 2025 | Cash interest expense | FY2025 | $102.00M | Raised |
| Aug 4, 2025 | General and administrative expenses | FY2025 | $50.00M | Reaffirmed |
| Feb 19, 2025 | Normalized FFO | FY2025 | $1.43 – $1.46 | New |
| Feb 19, 2025 | Net Income | FY2025 | $0.67 – $0.70 | New |
| Feb 19, 2025 | FFO | FY2025 | $1.42 – $1.45 | New |
| Feb 19, 2025 | General and administrative expenses | FY2025 | $50.00M | New |
| Feb 19, 2025 | Normalized AFFO | FY2025 | $1.48 – $1.51 | Raised |
| Feb 19, 2025 | AFFO | FY2025 | $1.47 – $1.50 | Raised |
| Oct 31, 2024 | Net Income | FY2024 | $0.48 – $0.49 | Lowered |
| Oct 31, 2024 | Normalized AFFO | FY2024 | $1.43 – $1.44 | Raised |
| Oct 31, 2024 | AFFO | FY2024 | $1.41 – $1.42 | Raised |
| Oct 31, 2024 | Normalized FFO | FY2024 | $1.39 – $1.40 | Raised |
| Oct 31, 2024 | FFO | FY2024 | $1.35 – $1.36 | Lowered |
| Aug 7, 2024 | Normalized FFO | FY2024 | $1.36 – $1.39 | Raised |
| Aug 7, 2024 | Net Income | FY2024 | $0.48 – $0.51 | Lowered |
| Aug 7, 2024 | FFO | FY2024 | $1.33 – $1.36 | Lowered |
| Aug 7, 2024 | Normalized AFFO | FY2024 | $1.41 – $1.44 | Raised |
| Aug 7, 2024 | AFFO | FY2024 | $1.39 – $1.42 | Raised |
| May 8, 2024 | Net Income | FY2024 | $0.53 – $0.57 | Reaffirmed |
| May 8, 2024 | Normalized FFO | FY2024 | $1.34 – $1.38 | Raised |
| May 8, 2024 | Normalized AFFO | FY2024 | $1.39 – $1.43 | Raised |
| May 8, 2024 | AFFO | FY2024 | $1.38 – $1.42 | Raised |
| May 8, 2024 | FFO | FY2024 | $1.33 – $1.37 | Lowered |
| Feb 27, 2024 | Normalized FFO | FY2024 | $1.34 – $1.38 | New |
| Feb 27, 2024 | Net Income | FY2024 | $0.53 – $0.57 | New |
| Feb 27, 2024 | Normalized AFFO | FY2024 | $1.39 – $1.43 | Raised |
| Feb 27, 2024 | AFFO | FY2024 | $1.38 – $1.42 | Raised |
| Feb 27, 2024 | FFO | FY2024 | $1.33 – $1.37 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Sabra Health Care REIT filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Update
See a number that looks wrong?